DH
Therapeutic Areas
Juvena Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| JUV-161 | Myotonic Dystrophy Type 1 | Phase 1 |
| Undisclosed Programs | Obesity, Sarcopenia, Lung & Liver Diseases | Pre-clinical |
| Drug | Indication | Phase |
|---|---|---|
| JUV-161 | Myotonic Dystrophy Type 1 | Phase 1 |
| Undisclosed Programs | Obesity, Sarcopenia, Lung & Liver Diseases | Pre-clinical |